Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CSPC Pharmaceutical Group...

    OTC: CHJTF · Real-Time Price · USD
    1.27
    0.00 (0.00%)
    At close: Aug 05, 2025, 12:35 PM
    1.27
    0.00%
    After-hours: Aug 13, 2025, 08:00 PM EDT

    CSPC Pharmaceutical Income Statement

    Financials in HKD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 17.5B n/a 16.6B 7.78B 8.03B 8.05B 17.2B 18.85B 17B 16.59B
    Cost of Revenue
    		 4.97B n/a 4.79B 2.23B 2.31B 2.53B 4.95B 5.16B 4.16B 3.96B
    Gross Profit
    		 12.52B n/a 11.82B 5.55B 5.72B 5.52B 12.25B 13.69B 12.84B 12.63B
    Operating Income
    		 3.98B n/a 3.79B 1.93B 1.91B 1.75B 3.73B 4.18B 3.79B 3.73B
    Interest Income
    		 n/a n/a 145.93M n/a 141.15M n/a 161.64M 118.91M 131M 90M
    Pretax Income
    		 4.08B n/a 4.04B 1.93B 1.9B 1.78B 4.35B 4.49B 3.83B 4.39B
    Net Income
    		 3.25B n/a 3.14B 1.53B 1.54B 1.43B 3.51B 3.58B 3.08B 3.67B
    Selling & General & Admin
    		 5.81B n/a 2.44B 2.45B 2.69B 2.75B 2.52B 7.23B 6.85B 6.96B
    Research & Development
    		 2.73B n/a 2.73B 1.37B 1.3B 1.01B 2.36B 2.28B 2.2B 1.94B
    Other Expenses
    		 n/a n/a 1.79M 136.94M n/a 16.64M 371.94M n/a n/a n/a
    Operating Expenses
    		 8.54B n/a 8.02B 3.77B 4.02B 3.77B 8.52B 9.51B 9.05B 8.9B
    Interest Expense
    		 n/a n/a 9.02M 6.16M 6.29M 4.43M 17.02M 11.74M 3.49M 5.74M
    Selling & Marketing Expenses
    		 5.13B n/a 2.11B 2.13B 2.41B 2.49B 2.22B n/a n/a n/a
    Cost & Expenses
    		 13.52B n/a 12.81B 6B 6.33B 6.31B 13.47B 14.67B 13.21B 12.85B
    Income Tax Expense
    		 805.53M n/a 748.85M 341.23M 311.65M 311.86M 738.14M 836.07M 732.49M 664.48M
    Shares Outstanding (Basic)
    		 11.84B 11.85B 11.85B 11.88B 11.89B 11.92B 11.93B 11.92B 11.95B 11.95B
    Shares Outstanding (Diluted)
    		 11.84B 11.85B 11.85B 11.88B 11.89B 11.92B 11.93B 11.92B 11.95B 11.96B
    EPS (Basic)
    		 0.27 0.14 0.26 0.13 0.28 0.12 0.29 0.30 0.26 0.31
    EPS (Diluted)
    		 0.27 0.14 0.26 0.13 0.28 0.12 0.29 0.30 0.26 0.31
    EBITDA
    		 4.57B n/a 4.42B 1.93B 1.91B 1.79B 4.36B 4.76B 4.32B 4.25B
    EBIT
    		 3.98B n/a 1.79B 1.93B 1.91B 1.75B 2B 1.96B 3.87B 3.72B
    Depreciation & Amortization
    		 590.95M n/a 630.85M -39.59K 599.69M 40.26M 634.02M 580.55M 525.44M 515.51M

    Add to Watchlist